1. Introduction {#s0005}
===============

Trypanosomosis is a chronic debilitating haemoparasitic disease of man and domestic animals characterised by parasitaemia, pyrexia, anaemia, loss of condition, reduced productivity and death in some cases [@b0005], [@b0010]. The disease accounts for over 3 million livestock and 55,000 human deaths, respectively, annually [@b0015], [@b0020]. It has negative impact on food production and economic growth in many parts of the world, particularly, sub-Saharan Africa, with estimated direct annual losses to producers and consumers exceeding US\$1 million [@b0025], [@b0030].

Oxidative stress, defined as imbalance between free radical generation and free radical scavenging, has been postulated to play a pivotal role in the pathogenesis of trypanosomosis [@b0035], [@b0040]. Free radicals cause lipoperoxidation in the body and an increase in the production of these radicals leads to overproduction of malondialdehyde (MDA). MDA is one of the best known degradation products of lipid peroxidation due to free radicals and therefore, can be used as a marker of cell membrane injury due to lipid peroxidation. The polyunsaturated fatty acids of the erythrocyte membrane are the main target for free radical lipoperoxidation [@b0045], [@b0050]. By-products of this lipid peroxidation have been reported to produce changes in the structures and functions of cell membrane, leading to decreased membrane fluidity, increased membrane permeability, inactivation of membrane-bound enzymes and loss of essential fatty acids [@b0045], [@b0055]. The end result of these changes on the surface of erythrocytes is increased erythrocyte osmotic fragility [@b0060]. This may ultimately lead to anaemia and poor distribution of nutrient in the body. Control of anaemia in trypanosome-infected cattle is more important for survival, weight gain and productivity than control of parasitaemia [@b0065]. Oxidative stress may be harmful to both the host and the trypanosome, but it is mainly due to a defensive reaction of the host (or vector) against the presence of the trypanosome. Both the host and the parasite dispose of an antioxidant defence system. However, the system of the mammalian host (having glutathione as the major intracellular antioxidant) is different from that of the trypanosomes (having trypanothione as the main defence system against oxidative stress).

Currently, only three trypanocides are available for controlling tsetse-transmitted trypanosomosis in domestic ruminants. These are isometamidium and homidium which have both prophylactic and therapeutic effects, and diminazene aceturate which has only therapeutic properties. It is estimated that 35 million doses of these drugs are used in Africa annually for the control of the disease [@b0070]. The toxicity associated with the use of these drugs and the resistance developed against them by trypanosomes are some of the problems associated with the trypanosomosis. Drug-screening activities from plants have started decades back, and an emerging number of studies have now been developed and reported so far to discover drugs from medicinal plants that can help to combat trypanosomosis. The efforts have been geared towards medicinal plants with significant trypanocidal effect but fewer side effects.

*Lawsonia inermis* (Henna) is a branched glaborous shrub or a small tree (2--6 m high) belonging to the family Lythraceae [@b0075]. It is widely used for traditional and prophetic medicine in Africa, Asia, and Middle East [@b0080]. The plant is reputed to be used for treatment of plethora of diseases, such as trypanosomosis, malaria, fungal, viral, and bacterial infections; cancer and rheumatoid arthritis [@b0085], [@b0090], [@b0095], [@b0100], [@b0105]. Since the search for a vaccine against trypanosomosis remains elusive for now [@b0110], there is an urgent need to find more efficacious drugs, particularly, from traditional medicinal plants to combat the menace of the disease. Thus, the aim of this study was to elucidate the antitrypanosomal property of *L. inermis* against experimental *Trypanosoma congolense* infection in Wistar rats.

2. Materials and methods {#s0010}
========================

2.1. Plant collection and identification {#s0015}
----------------------------------------

Fresh leaves of *L. inermis* were collected from the main campus of Ahmadu Bello University, Zaria, Nigeria. The leaves, flowers and seeds of the plants were sent to the Herbarium, Department of Biological Sciences, Ahmadu Bello University Zaria, Nigeria for identification. A specimen voucher Number (10461) was assigned to the plant. The leaves were dried to a constant weight at room temperature in the laboratory. The dried sample was ground into powder using mortar and pestle and kept in a polythene bag until required.

2.2. Plant extraction, concentration and phytochemical screening of the extract {#s0020}
-------------------------------------------------------------------------------

Three hundred grams of the powdered leaf of *L. inermis* was cold extracted in a percolator using 900 ml of methanol as solvent. The mixture was allowed to stand in the percolator for 72 h. Thereafter, the liquid extract was drained into a clean bottle. The extracted powder was rinsed off with 100 ml of fresh solvent and added to the initial solution collected. The liquid extract was concentrated to dryness over water bath.

2.3. Phytochemical screening {#s0025}
----------------------------

Phytochemical screening to detect the presence of alkaloids, flavonoids, saponins, tannins, glycosides, triterpenes and steroids on the extract was carried out as described by Trease and Evans [@b0115].

2.4. Experimental animals {#s0030}
-------------------------

Wistar rats of both sexes weighing between 90 and 100 g were obtained from Nigerian Institute for Trypanosomiasis Research (NITR), Kaduna. The animals were kept for 2 months in the animal house before the commencement of the experiment. They were housed in clean plastic cages with wood shavings as beddings. The beddings were changed twice in a week. The rats were fed on standard rat feed and given access to clean water *ad libitum*. The ethical approval for the use of rats was obtained from Ethical Committee on Animal Use and Care, Ahmadu Bello University, Zaria.

2.5. Test organism {#s0035}
------------------

*T. congolense* was obtained from the Department of Vector and Parasite, Nigerian Institute for Trypanosomiasis and Onchocerciasis Research (NITR), Kaduna. The parasite was maintained in the laboratory by continuous passage in rats until required. Each cycle of passage was done when parasitaemia was in the range of 35--40 parasites per field. For several passages, about 3 ml of blood was obtained from an infected rat by cardiac puncture after light chloroform anaesthesia into a 5 ml syringe and emptied into a vial containing 9 ml of physiological buffered saline (PBS). About 1 × 10^6^ parasite in 0.2 ml blood/PBS solution was injected intraperitoneally (IP) into a rat previously unexposed to trypanosomal infection. Parasitaemia was monitored daily using the method of Herbert and Lumsden [@b0120].

2.6. Inoculation of experimental animals {#s0040}
----------------------------------------

For inoculation of experimental rats, blood was obtained from a donor rat at peak parasitaemia by sacrificing the rat via jugular venisection after light chloroform anaesthesia into a vial containing PBS. About 1 × 10^6^ parasite in 0.2 ml blood/PBS solution was injected IP into a rat previously unexposed to trypanosomal infection.

2.7. Determination of median lethal dose 50 (LD~50~) {#s0045}
----------------------------------------------------

The median lethal dose (LD~50~) was determined as described by Lorke [@b0125]. In the initial phase, 9 rats of both sexes were randomly divided into three groups of 3 rats each. Groups 1, 2 and 3 were treated IP with crude methanol extract leaf extract of *L. inermis* at 10, 100 and 1000 mg/kg, respectively. The rats were then observed over 48 h for signs of toxicity and mortality. In the second phase of the study, 3 rats for each extract were assigned into 3 groups of 1 rat each. The animals were individually administered 2, 6, and 8 mg/kg of crude methanol leaf extract of *L. inermis*. The LD~50~ was then computed as geometric mean of highest dose that did not kill the rat and lowest dose that killed the rat.

2.8. Experimental grouping {#s0050}
--------------------------

Twenty-five adult Wistar rats of both sexes were individually infected, IP, with 10^6^ of *T. congolense* per ml of blood. Immediately after the establishment of infection, the rats were randomly divided into five groups of 5 rats each. Rats in groups I, II, and III were treated with crude methanol extract of the leaf of *L. inermis* at 500, 250 and 125 mg/kg, respectively, per os for 7 consecutive days. Similarly, rats in group V were given PBS 2 ml/kg for 7-day; while rats in group IV were treated with diminazene aceturate 3.5 mg/kg IP once.

2.9. Determination of parasitaemia in experimental rats {#s0055}
-------------------------------------------------------

The treated rats were observed daily for development of parasitaemia throughout the duration of the experiment. Parasitaemia was assessed using wet mount method. A drop of blood was collected on a clean microscope slide from the tail of each rat, covered with a cover slip and observed for parasitaemia under light microscope at ×400 magnification. The number of parasites per field was converted to the number of parasites per ml of blood using a standard chart [@b0120].

2.10. Determination of packed cell volume (PCV) {#s0060}
-----------------------------------------------

The PCV of rats from all the groups was determined on days 8 and 15 by collecting blood from tail vein of each rat in a heparinized capillary tube and centrifuged the tube at 3000*g* for 10 min, where after the PCV was measured using a haematocrit reader. At the end of the experiment (day 21), the animals were sacrificed by severing the jugular vein. At that occasion blood was collected from each rat and the PCV determined.

2.11. Determination of erythrocyte osmotic fragility (EOF) {#s0065}
----------------------------------------------------------

The EOF test was carried out as described by Faulkner and King [@b0130]. Briefly, 5 ml of different concentrations (0.0%, 0.1%, 0.3%, 0.5%, 0.7% and 0.9%) of buffered sodium chloride pH 7.4 was poured into labelled test tubes and 0.02 ml of blood collected at day 21 from each rat was added into the respective test tubes. The contents were mixed gently and allowed to stand for 30 min at room temperature. The test tubes were centrifuged at 2000*g* for 5 min. Thereafter, 4 ml of the supernatant was transferred to a clean glass cuvette and the absorbance measured at 540 nm wavelength with spectrophotometer (Spectronic 20, Bausch and Lomb, USA). The percentage haemolysis for each sample was calculated as:$$\%\mspace{6mu}\text{Haemolysis} = \text{optical\ density\ of\ test\ solution}/\text{optical\ density\ of\ standard\ solution(distiled\ water)} \times 100\text{.}$$

2.12. Determination of malondialdehyde (MDA) {#s0070}
--------------------------------------------

Serum concentrations of MDA were measured as described by Draper and Hadley [@b0135]. Briefly, 0.5 ml of serum from each infected rat was pipetted into a centrifuge tube and 2.5 ml of 100 g/L trichloroacetic acid (TCA) solution was added to it and then placed in boiling water bath for 15 min. Thereafter, it was cooled in tap water and centrifuged at 1000*g* for 10 min. Then 2 ml of the supernatant was taken and added to 1 ml of 6.7 g/L thiobarbituric acid (TBA) in a test tube and placed in boiling water bath for 15 min. It was then cooled in tap water and its absorbance was measured at 532 nm with spectrophotometer (spectrumlab 23A China). One ml of 10% TCA and 1 ml of 0.67% TBA was used as the blank. The intensity of the pink pigment formed from MDA-TBA condensation was measured by spectrometer and indicates the extent of lipid peroxidation.

2.13. Statistical analysis {#s0075}
--------------------------

Values obtained were expressed as mean ± standard error of mean (±SEM). Analysis of variance (ANOVA) was used followed by Tukey's post hoc test for multiple comparisons of groups using GraphPad Prism version 5.03. Values of *P* \< 0.05 were considered significant.

3. Results {#s0080}
==========

3.1. Phytochemical screening {#s0085}
----------------------------

The crude methanol extract of *L. inermis* was positive for the presence of alkaloids, carbohydrates, triterpenes and steroids, cardiac glycosides, saponin glycosides, tannins and flavanoids.

3.2. Acute toxicity {#s0090}
-------------------

The crude methanol leaf extract of *L. inermis* did not show any sign of toxicity or mortality even at highest dose of 5000 mg/kg.

3.3. Effect of treatment on the level of parasitaemia {#s0095}
-----------------------------------------------------

The effect of treatment on the level of parasitaemia in all the animals treated is shown in [Fig. 1](#f0005){ref-type="fig"}. From day six onwards, mean daily parasitaemia was significantly lower (*P* \< 0.05) in rats treated with 250 mg/kg of the extract than rats administered PBS. However, rats treated with 500 and 125 mg/kg of the extract treated did not show significant suppression of parasitaemia. Nonetheless, diminazene treated group cleared parasites from the blood 24 h post-treatment until day 13 when parasitic relapse occurred.Fig. 1Effect of methanol extract of the leaf of *L. inermis* on the level of parasitaemia in rats infected with *T. congolense*. MLELI = Methanol leaf extract of *L. inermis*; DA = Diminazene aceturate; PBS = Physiologic buffered phosphate saline.

3.4. Survival periods of rats treated with leaf extract of *L. inermis* {#s0100}
-----------------------------------------------------------------------

The effect of treatment with the methanol leaf extract of *L. inermis* (MLELI) on the survival periods of rats is shown in the [Fig. 2](#f0010){ref-type="fig"}. Rats treated with 500 and 250 mg/kg MLELI had significantly (*P* \< 0.05) longer survival periods than the rats treated with 125 mg/kg LLELI and PBS. Mortality was first noticed on days 14 and 12 in the MLELI 125 mg/kg and PBS groups, respectively, culminating to the death of all the rats in MLELI 125 mg/kg and PBS on day 18.Fig. 2Effect of treatment with extract of the leaf *Lawsonia inermis* on mean survival periods of experimental rats. ^a,b^Means with different superscript letters are statistically significant (*P* \< 0.05). MLELI = Methanol leaf extract of *L. inermis*; DA = Diminazene aceturate; PBS = Physiologic buffered phosphate saline.

3.5. Effect of treatment with *L. inermis* extract on mean weekly packed cell volume (PCV) {#s0105}
------------------------------------------------------------------------------------------

The PCV was higher in all the extract treated groups at weeks 1 and 2 than PBS treated group ([Fig. 3](#f0015){ref-type="fig"}). The PCV of rats treated with 250 mg/kg of the extract at week 2 was significantly higher (*P* \< 0.05) than the PCV of rats in PBS group. Also, among the groups treated with the leaf extract, rats treated with 250 mg/kg of the extract had the highest PCV at weeks 1 and 2, though not statistically significant (*P* \> 0.05) when compared to other extract treated groups.Fig. 3Effect of treatment with extract of the leaf *Lawsonia inermis* on mean weekly PCV of experimental rats. ^a,b^Means with different superscript letters are statistically significant (*P* \< 0.05). MLELI = Methanol leaf extract of *L. inermis*; DA = Diminazene aceturate; PBS = Physiologic buffered phosphate saline.

3.6. Effect of *L. inermis* extract on erythrocyte osmotic fragility (EOF) of treated rats {#s0110}
------------------------------------------------------------------------------------------

The ameliorative effect of the crude methanol extract of *L. inermis* on experimental *T. congolense* infection is shown in [Fig. 4](#f0020){ref-type="fig"}. The percentage EOF of extract treated groups was significantly lower (*P* \< 0.05) at 0.1% and 0.3% NaCl concentrations when compared to PBS group. While rats treated with 500 mg/kg had lowest EOF at 0.3% NaCl concentration, rats treated with 250 mg/kg of extract had the lowest EOF at 0.1% NaCl concentration. However, diminazene (3.5 mg/kg) treated rats have significantly higher (*P* \< 0.05) values of EOF when compared with extract treated groups.Fig. 4Effect of *Lawsonia inermis* extract on EOF of treated rats experimentally infected with *T. congolense*. ^a,b^Means with different superscript letters are statistically significant (*P* \< 0.05). MLELI = Methanol leaf extract of *L. inermis*; DA = Diminazene aceturate; PBS = Physiologic buffered phosphate saline.

3.7. Effect of *L. inermis* extract on serum malondialdehyde (MDA) concentrations of treated rats {#s0115}
-------------------------------------------------------------------------------------------------

The effect of treatment on serum MDA concentration is shown in [Fig. 5](#f0025){ref-type="fig"}. There was an increase in the serum MDA concentration of rats in the control (PBS) group when compared to extract treated groups. The serum MDA concentration of rats treated with 250 mg/kg of the extract was significantly lower (*P* \< 0.05) than in rats treated with PBS. Furthermore, serum concentration of rats treated with 250 mg/kg group was lower than that of rats treated with 500 mg/kg and diminazene 3.5 mg/kg groups though not statistically significant (*P* \> 0.05). However, the serum concentration of MDA in diminazene aceturate treated group is lower (*P* \> 0.05) than the PBS treated group.Fig. 5Effect of *Lawsonia inermis* extract on serum MDA of treated rats experimentally infected with *T. congolense*. ^a,b^Means with different superscript letters are statistically significant (*P* \< 0.05). MLELI = Methanol leaf extract of *L. inermis*; DA = Diminazene aceturate; PBS = Physiologic buffered phosphate saline.

4. Discussion {#s0120}
=============

The absence of any apparent toxic signs in rats treated with the extract even at 5000 mg/kg showed that the leaf extract of *L. inermis* is relatively safe. Any substance that is not toxic to animals at a dose of up to 5000 mg/kg is relatively safe for use as therapeutic agent [@b0125]. According to the World Health Organisation acute toxicity rankings [@b0140], the extract could be described as unlikely to be associated with hazard when administered as a drug. This may underscore the reason why traditional herbalists use a wide range of doses of decoction and infusion made from the plant.

The *L. inermis* extract used in this study was able to suppress parasite growth. Surprisingly, the activity of the extract was higher at the dose of 250 mg/kg when compared with the dose of 500 mg/kg. This agrees with the finding of Das et al. [@b0145], who reported better efficacy of extract of *Argemone mexicana* at lower dose than at higher dose. This effect may perhaps be attributed to the antioxidant action of the extract. It has been shown that antioxidants prevent the deleterious effects of *Trypanosoma brucei* [@b0150]. Also, antioxidant action is maintained at certain dose above which it becomes a pro-oxidant with resultant lower pharmacological action and deleterious effect on the animal host. This may explain the poor antitrypanosomal effect observed at the higher dose of 500 mg/kg in this study. Bouayed and Bohn [@b0155] and Martins [@b0160] observed that at higher doses, an antioxidant becomes pro-oxidant thereby disrupting redox balance. Optimal doses of antioxidants are crucial for maintaining homeostasis [@b0165], [@b0170]. Besides, better antitrypanosomal effect at 250 mg/kg than 500 mg/kg suggests that the former is the optimal dose which conforms to the drug-receptor occupation theory. This theory states that drugs give their highest efficacy at full receptor occupation and no further effect is observed with further increase in dose [@b0175]. Therefore, 250 mg/kg of the extract may be the optimal dose with full receptor occupation and also optimal dose for its antioxidant effect.

*Trypanosoma brucei brucei* has been shown to induce erythrocyte osmotic fragility (EOF) [@b0180]. The increase in EOF in the infected untreated group in the present study could be attributed partly to generation of free radicals which could have overwhelmed the host body antioxidant defence system resulting in loss of integrity of erythrocyte membrane and their subsequent lysis. Similarly, Umar et al. [@b0185] earlier reported that *T. bruei brucei* infection altered the host's antioxidant defence against free radicals. In this study, rats treated with *L. inermis* extract at 250 mg/kg ameliorated oxidative stress as observed by significantly lower values of EOF. This implied that the membrane of erythrocytes was protected from the deleterious effects of the trypanosome on the erythrocyte membrane. Antioxidants stabilize free radicals and ameliorate free-radical-induced damage to the cells [@b0190]. Anaemia in trypanosomosis has been attributed to injury to the membrane of erythrocytes resulting from either the lashing effect of the flagellum of trypanosomes on the erythrocyte membrane [@b0195], [@b0200]; or cleavage of sialic acid of the erythrocyte membrane by the sialidase of trypanosome [@b0205]. The leaf extract of *L. inermis* has shown to protect the erythrocyte membrane against trypanosome-induced-EOF and therefore, may ameliorate anaemia associated with trypanosome infection in animals. Since anaemia but not level of parasitaemia in the trypanosome-infected animals is primarily responsible for decrease in the productivity of such animals and loss of their condition [@b0065], [@b0210], it is possible that the leaf of *L. inermis* could be used to improve productivity of trypanosome-infected animals.

One of the end products of lipid peroxidation is MDA, which is measured by concentration of MDA in body tissues or serum [@b0040]. These products of lipid peroxidation produce changes in the structures and functions of the cell membrane, leading to decreased membrane fluidity, increased membrane permeability, inactivation of membrane-bound enzymes and loss of essential fatty acids [@b0045], [@b0055]. The end result of these changes on the surface of erythrocytes is increased erythrocyte osmotic fragility [@b0060]. The increase in the concentration of MDA in PBS group suggests an increase in the production of free radicals by *T. congolense*, resulting from imbalance between radical generating and radical scavenging activities. This observation agrees with the findings of earlier workers [@b0035], [@b0180], [@b0185]. The reduction in the concentration of MDA in *L. inermis* extract treated groups shows that the plant was able to ameliorate lipid peroxidation due to *T. congolense* infection. This observation further corroborates the results of EOF, which is an indirect index of measuring oxidative stress on erythrocyte membrane. It follows that methanol leaf extract of *L. inermis* enhances antioxidant defence against free radicals. Leaf of *L. inermis* has been reported to have an antioxidant effect against oxidative damage comparable to vitamin C [@b0215]. Furthermore, reduced EOF and lipid peroxidation caused by the leaf extract of *L. inermis* lend credence to higher PCV values obtained in the extract treated groups, probably resulting from the protective effect of the extract on the erythrocyte membrane against oxidative stress.

The higher values of EOF and MDA in the diminazene aceturate (DA) treated group compared to the lower values in the 250 mg/kg extract treated group show that DA does not have a protective effect on the membrane of erythrocytes and probably lacks antioxidant effect. DA achieves its trypanocidal effect by binding to kinetoplast deoxyribonucleic acid (kDNA) and induces irreversible loss of the kDAN [@b0220], [@b0225]. On the other hand, the lower value of MDA in the DA treated group when compared with the PBS treated group may be a result of clearance of parasites from the blood of the treated rats, which precludes trypanosome-induced lipoperoxidation (oxidative damage) of the membrane of erythrocytes. This agrees with the finding of Kobo et al. [@b0180] who reported lower values of MDA in *T. brucei brucei* infected rats treated with diminazene aceturate.

The antitrypanosomal effect of *L. inermis* vis-à-vis its antioxidant property observed in the present study could be attributable to the presence of one or combined effects of secondary metabolites detected. Antitrypanosomal effects of plant extracts are associated with the presence of one or more biologically active ingredients [@b0085], [@b0230]. Phytochemical constituents such as flavonoids and phenols are known to possess good antioxidant activities [@b0235].

The antitrypanosomal activities of leaf of *L. inermis* observed in this study are not corroborated by the study of Wucherokke et al. [@b0240]. This discrepancy could be attributed to differences in plant age/developmental stage, season and plant collection sites between both studies. In this study, the plant was collected in Zaria, Nigeria, which falls within the northern Guinea Savannah zone of Nigeria. Age, species, location, season of collection of plant and plant part affect the pharmacological activity of plant extracts [@b0245]. Plants cultivated under different environmental conditions produce different phytochemical profiles or different amounts of individual components [@b0250].

5. Conclusion {#s0125}
=============

The results of this study validate the traditional use of the leaf of *L. inermis* in treating trypanosomosis. The ability of the leaf of *L. inermis* to enhance erythrocyte membrane integrity and maintain a high erythrocyte count in trypanosome-infected rats can be exploited to reduce anaemia and thus, improve productivity of trypanosome-ridden animals in trypanosome-endemic areas.
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